Ruocco et al. have suggested that the administration of TGF-β-blocking agent can significantly increase excitotoxic lesions after cerebral ischemia [28] and indicated that TGF-β can diminish ischemia-induced endothelial dysfunction [28]. Here, TGFB1 is linked to brain ischemia.